Inflammation Control and Tumor Growth Inhibition of Ovarian Cancer by Targeting Adhesion Molecules of E-Selectin

Bowen Yang1,2, Shanmei Yin3, Zishuo Zhou3

  • 1Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, Chengdu 610041, China.

Cancers
|April 13, 2023
PubMed
Abstract

Insights

E-selectin-binding peptide (ESBP) conjugated nanoparticles target ovarian cancer cells, enhancing drug delivery and inhibiting tumor growth. This targeted approach shows promise for preclinical epithelial ovarian cancer therapy.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Oncology

Background:

  • Epithelial ovarian cancer (EOC) remains a significant health challenge with limited effective targeted therapies.
  • Targeting adhesion molecules like E-selectin offers a potential strategy for specific cancer cell recognition and drug delivery.
  • Developing novel drug delivery systems (DDS) is crucial for improving therapeutic efficacy and reducing side effects.

Purpose of the Study:

  • To design and evaluate an ovarian cancer-directed drug delivery system utilizing E-selectin-binding peptide (ESBP).
  • To investigate the targeting capabilities and therapeutic effects of ESBP-conjugated bovine serum albumin (BSA) polymerized nanoparticles (ESBP-BSANPs) loaded with paclitaxel (PTX).
  • To elucidate the mechanisms underlying the anti-tumor activity of ESBP-BSANPs-PTX in both in vitro and in vivo models.

Main Methods:

  • Preparation and characterization of BSA polymerized nanoparticles (BSANPs) and ESBP-BSANPs loaded with paclitaxel (PTX).
  • In vitro assessment of nanoparticle targetability (using FITC-labeled nanoparticles) and cytotoxicity (MTT assay) in ovarian cancer cells and relevant cell lines.
  • In vivo evaluation of targeting properties and anti-tumor efficacy in a mouse model of ovarian cancer.

Main Results:

  • ESBP-BSANPs demonstrated enhanced in vitro cellular uptake compared to control nanoparticles.
  • ESBP-BSANPs-PTX exhibited significantly higher cytotoxicity against ovarian cancer cells than PTX alone.
  • In vivo studies confirmed the targeting ability and effective tumor inhibition by ESBP-BSANPs, with increased apoptosis and reduced cell migration.

Conclusions:

  • ESBP-BSANPs-PTX effectively improve paclitaxel targetability, delivering potent, tumor-specific therapeutic activity.
  • The developed drug delivery system shows significant promise for preclinical applications in epithelial ovarian cancer treatment.
  • Targeting E-selectin with ESBP-functionalized nanoparticles represents a viable strategy for enhancing ovarian cancer therapy.

Related Concept Videos

Selectins01:25

Selectins

Cell adhesion is  an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
3.4K
Cell Adhesion Molecules - Types and Functions01:20

Cell Adhesion Molecules - Types and Functions

Cell adhesion molecules (CAMs) are pivotal to multicellularity and the coordinated functioning of tissues and organ systems. They enable physical interactions between cells and provide mechanical strength to tissues. They also function as receptors for signal transmission across the plasma membrane. The CAMs are broadly classified into four families - integrins, cadherins, selectins, and immunoglobulin-like CAMs (IgCAMs).
CAM Families
The Integrin family of proteins is primarily  involved...
6.9K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.7K